Unlock stock picks and a broker-level newsfeed that powers Wall Street.
13.74
+1.45
+(11.80%)
At close: April 2 at 4:00:01 PM EDT
12.01
-1.73
(-12.59%)
Pre-Market: 4:11:42 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 14 | 14 |
| Avg. Estimate | -0.71 | -0.71 | -2.86 | -2.61 |
| Low Estimate | -0.77 | -0.8 | -3.33 | -3.16 |
| High Estimate | -0.57 | -0.51 | -2.32 | -1.67 |
| Year Ago EPS | -0.78 | -0.59 | -2.57 | -2.86 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 17 | 17 |
| Avg. Estimate | 3.24M | 7.79M | 29.84M | 128.72M |
| Low Estimate | -- | -- | -- | 25.34M |
| High Estimate | 34.55M | 50M | 138.2M | 284.12M |
| Year Ago Sales | -- | -- | -- | 29.84M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 331.34% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.66 | -0.69 | -0.63 | -0.85 |
| EPS Actual | -0.78 | -0.59 | -0.63 | -0.67 |
| Difference | -0.12 | 0.1 | 0 | 0.18 |
| Surprise % | -17.47% | 14.95% | 0.30% | 20.79% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.71 | -0.71 | -2.86 | -2.61 |
| 7 Days Ago | -0.8 | -0.79 | -2.86 | -2.61 |
| 30 Days Ago | -0.85 | -0.84 | -2.86 | -2.58 |
| 60 Days Ago | -0.82 | -0.81 | -3.01 | -2.27 |
| 90 Days Ago | -0.82 | -0.81 | -2.93 | -1.94 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 6 | -- |
| Up Last 30 Days | 2 | 2 | 6 | -- |
| Down Last 7 Days | 2 | 3 | 4 | 5 |
| Down Last 30 Days | 1 | 2 | 3 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DNLI | 9.26% | -19.85% | -11.25% | 8.82% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
| Reiterates | B. Riley Securities: Buy to Buy | 3/5/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/3/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Initiated | Deutsche Bank: Buy | 2/11/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 1/28/2025 |
Related Tickers
RNA Avidity Biosciences, Inc.
29.77
+11.33%
ZLAB Zai Lab Limited
36.43
-2.31%
CYTK Cytokinetics, Incorporated
40.25
+7.33%
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
SLNO Soleno Therapeutics, Inc.
73.67
+7.93%
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
DBVT DBV Technologies S.A.
7.70
+19.20%
APLS Apellis Pharmaceuticals, Inc.
23.00
+1.41%
ACLX Arcellx, Inc.
67.23
+10.76%
PCVX Vaxcyte, Inc.
33.69
+4.53%